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Percutaneous Transabdominal Approach
for the Treatment of Endoleaks after
Endovascular Repair of Infrarenal
Abdominal Aortic Aneurysm
Objective: The purpose of this study was to evaluate the technical feasibility
and clinical efficacy of percutaneous transabdominal treatment of endoleaks after
endovascular aneurysm repair.
Materials and Methods: Between 2000 and 2007, six patients with type I 
(n = 4) or II (n = 2) endoleaks were treated by the percutaneous transabdominal
approach using embolization with N-butyl cyanoacrylate with or without coils. Five
patients underwent a single session and one patient had two sessions of
embolization. The median time between aneurysm repair and endoleak treatment
was 25.5 months (range: 0-84 months). Follow-up CT images were evaluated for
changes in the size and shape of the aneurysm sac and presence or resolution of
endoleaks. The median follow-up after endoleak treatment was 16.4 months
(range: 0-37 months).
Results: Technical success was achieved in all six patients. Clinical success
was achieved in four patients with complete resolution of the endoleak confirmed
by follow-up CT. Clinical failure was observed in two patients. One eventually
underwent surgical conversion, and the other was lost to follow-up. There were
no procedure-related complications.
Conclusion: The percutaneous transabdominal approach for the treatment of
type I or II endoleaks, after endovascular aneurysm repair, is an alternative
method when conventional endovascular methods have failed.
ndoleaks represent one of the most common major complications
encountered after endovascular aneurysm repair. Management of
endoleaks remains somewhat controversial. Secondary intervention is
mandatory in most cases with a type I endoleak because of the high risk of rupture (1,
2). Usually, type II endoleaks with a growing aneurysm sac are treated, while those
with a shrinking sac are observed (3). However, the most effective methods for
managing type II endoleaks are a matter of debate.
Transcatheter embolization of endoleaks is a less invasive treatment technique; it
may provide a better approach to patient management than open surgical repair.
Embolization can be performed through the transarterial approach or direct percuta-
neous puncture of the aneurysm sac via the translumbar (left side) or transcaval (right
side) approaches. However, few cases of transabdominal embolization have been
reported for repair of endoleaks (4-6). In this study, we report our experience with
embolization using a percutaneous transabdominal approach for the treatment of type
I and II endoleaks. 
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MATERIALS AND METHODS
Patient Group and Study Design
Between 2000 and 2007, 141 patients underwent
endovascular aneurysm repair at our institution, and 33
endoleaks (23%) occurred. Based on follow-up imaging,
the endoleaks were categorized as type I in 12 patients
(9%), type II in 16 patients (11%), type III in two patients
(1%), type IV in one patient (1%), and type V in two
patients (1%). Initial treatment methods for the endoleaks
are described in Table 1. Among the 33 patients with
endoleaks, six patients (five men, one woman; age range,
61-81 years; mean age, 68.2 years) with type I or type II
endoleaks underwent embolization by the transabdominal
approach using a liquid embolic agent, N-butyl cyanoacry-
late. Five patients had an aortoiliac bifurcated stent-graft
due to an infrarenal abdominal aortic aneurysm, and one
patient (No. 3) had an aortoiliac bifurcated stent-graft due
to a ruptured abdominal aortic aneurysm. Four patients
had a type I endoleak, and two had a type II endoleak.
Five patients underwent a single session and one patient
(No. 1) underwent two sessions of embolization. 
The indications for treatment of a type I or II endoleak,
at our institution, were evidence of a type I endoleak
during follow-up; or a type II endoleak with a significant
increase in the diameter of the aneurysm sac (≥ 5 mm
difference by CT in the largest minor axis cross-sectional
diameter of the aneurysm sac). Indications for a transab-
dominal procedure included a type I endoleak with failed
alternative endovascular options (n = 4; No. 1-4) and a
type II endoleak located at the anterior aspect of the stent-
graft with an enlarging endoleak sac (n = 2; No. 5, 6). The
failed endovascular procedures included balloon percuta-
neous angioplasty (n = 4; No. 1-4); aortic extender cuff
(stent-graft) (Zenith, Cook, Bloomington, IN) (n = 2; No. 3,
4), and Palmaz stent placement (Johnson & Johnson
Interventional System, Warren, NY) (n = 1; No. 3).
Combined coil embolization was necessary in two patients
to achieve repair of the endoleaks in cases of high-flow
massive endoleaks from the attachment site (No. 3, 4) and
in one case where the inferior mesenteric artery acted as
an exit route for the endoleak (No. 3). Before the
procedure, all patients received a medical evaluation and
were determined to be good candidates for the transab-
dominal procedure. The median time between the
endovascular aneurysm repair and embolization was 25.5
months (range: 0-84 months). The median follow-up after
embolization was 16.4 months (range: 0-37 months).
Preoperative and Follow-Up Imaging
Before the endovascular aneurysm repair, patients
underwent CT imaging including pre-contrast, arterial
phase, and 30-second delayed contrast enhanced images.
Patients had follow-up CT with the same protocol at 30
days; 3, 6, and 12 months; and yearly thereafter. The
largest minor axis cross-sectional diameter of the aneurysm
sac was measured. A size greater than or equal to a 5-mm
difference, by the CT imaging, in the largest minor axis
cross-sectional diameter of the aneurysm sac was consid-
ered clinically significant. 
Percutaneous Transabdominal Embolization 
Before percutaneous transabdominal embolization,
preoperative aortography and selective angiography were
performed via the transarterial approach. If treatment of
the endoleak via the transarterial approach failed, a
percutaneous transabdominal approach was immediately
attempted. Before the procedure, intravenous prophylactic
antibiotics (Cefazolin� 1 g [Yuhan Corp., Seoul, Korea]
and Tobramycin 100 mg [Daewoong Pharmaceutical Co.,
Seoul, Korea]) were given. With the patient in the supine
position, local anesthesia was administered at the puncture
site of the abdomen. The target site was identified as a
contrast-enhancing area of the aneurysm sac by CT (skin
puncture point, puncture angle, depth of aneurysm sac
from the skin) and color-flow ultrasound (US) guidance
Choi et al.
108 Korean J Radiol 11(1), Jan/Feb 2010
Table 1. Initial Treatment Methods for Endoleak in 33 Patients
Initial Treatment Method (Failure)
Endoleak Type Transarterial Translumbar Transabdominal Surgical Total Number
Approach Approach Approach Approach Observation
Type 1 10 (4) - - - - 12
Type 2 02 (1) 1 1 11 16
Type 3 - - - 2 - 02
Type 4 - - - - 01 01
Type 5 - - - - 02 02
Note.─ Transarterial approach includes conventional approach of endoleak treatment such as stent-graft extensions, cuffs, and Palmaz stent in 
cases with type l endoleak, and transarterial embolization of dominant feeding artery such as inferior mesenteric artery or lumbar arteries in cases with type
ll endoleak. 
was used. The endoleak sac was punctured using a 21-
gauge puncture needle (Chiba; Cook, Bloomington, IN)
under fluoroscopic and/or color-flow US guidance. Bony
landmarks and stent-graft marking bars were also
referenced under fluoroscopic guidance. In case of bowel
interposition at the anterior aspect of the aneurysm sac, the
sigmoid and transverse colon were filled with barium, and
the transabdominal approach was performed under fluoro-
scopic guidance to avoid colon injury. After confirmation
of arterial blood flowing through the puncture needle,
contrast media was injected to visualize the endoleak sac, a
0.018-inch guidewire was inserted, and the puncture tract
was dilated. Over the 0.035-inch guide wire, a 5-Fr
angiographic catheter was placed within the endoleak site,
and an angiogram of the aneurysm sac was performed to
evaluate the origin and outflow of the endoleak. 
Embolization of the endoleak sac and outflow vessels
was performed. A 2.8-Fr microcatheter (Progreat; Terumo,
Tokyo, Japan) was used when a more advanced endoleak
selection was necessary or when the selection of outflow
vessels was attempted. Before injection of N-butyl
cyanoacrylate (Histoacryl, B. Braun, Tuttlingen, Germany),
the catheter was flushed with 5% dextrose-water solution
to prevent precipitation. N-butyl cyanoacrylate liquid
adhesive was mixed with iodized oil (Lipiodol Ultra Fluid,
Guerbet, Aulnay-sous-Bois, France), ranging from 25% to
50% depending on the amount and velocity of blood flow
from the endoleak. After embolization, the puncture tract
was embolized using the N-butyl cyanoacrylate mixture.
The endpoint of the procedure was the nonvisualization
of blood flow within the aneurysm sac on a completion
transarterial angiogram. Technical success was defined as
successful embolization of the endoleak sac and complete
resolution of the endoleak on completion angiography.
Clinical success was defined as complete resolution of the
endoleak without enlargement of the aneurysm sac on
follow-up CT. 
RESULTS
Technical success was achieved in all six patients. One
patient (No. 1) required a second embolization session.
Clinical success was achieved in four patients. One patient
(No. 3) had decreased diameter of the aneurysm sac, while
three patients (No. 1, 5, 6) had an unchanged aneurysm
diameter. Two cases of clinical failure occurred (No. 2, 4);
they had persistent type I endoleaks with increased
diameter of the aneurysm sac on follow-up CT for which
surgical conversion was recommended. One patient (No. 2)
eventually underwent surgical conversion, and the other
patient (No. 4) was lost to follow-up. Combined coil
embolization was required for endoleak sac embolization
(No. 5) and for both sac and inferior mesenteric artery
embolization (No. 4). The results of the transabdominal
embolization for the treatment of endoleaks are
summarized in Figure 1. 
There were no procedure-related complications such as
intraperitoneal bleeding, ischemic bowel injury, bowel
perforation, or infection in the aneurysm sac or graft.
Patient No. 3, an 81-year-old man who had a successful
embolization, died eight months after the procedure due to
sudden cardiac death that was unrelated to the procedure. 
DISCUSSION
Compared with open repair of infrarenal abdominal
aortic aneurysms, endovascular aneurysm repair is less
invasive and results in significantly better perioperative
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Fig. 1. Results of transabdominal
embolization in six patients.
outcomes, including fewer systemic complications, shorter
operative time, lower use of postoperative mechanical
ventilation, and shorter hospital stay, resulting in a lower
risk of perioperative mortality (7, 8). However, secondary
interventions are common in patients after endovascular
aneurysm repair, and new complications such as
incomplete exclusion of blood flow to the aneurysm sac,
defined as an endoleak by White et al. (9), have led to the
stent-graft procedure. Even though the technical innova-
tion for of the stent-graft has been performed (10), correc-
tion of endoleaks is one of the major causes of secondary
intervention during the primary admission or within 30
days of aneurysm repair (7). 
Clinical management of endoleaks varies according to
the different types. Type I and III endoleaks require
treatment without delay, but the efficacy of management
for type II endoleaks is a subject of debate (3, 11-14). At
our institution, type II endoleaks are treated only when the
aneurysm sac has grown by 5 mm or more during follow-
up. Conventional methods for the management of type I
endoleaks are stent-graft extensions, cuffs, or Palmaz
stents. Stent-graft extensions or cuffs can be applied only if
sufficient native aorta is available proximally or distally to
support the stent (15-17). When conventional methods fail
or devices are unavailable, N-butyl cyanoacrylate
embolization via a transabdominal approach can be
attempted before resorting to open surgical repair. The
conventional approach for a type II endoleak is transarter-
ial (18-20). If transarterial approaches fail, translumbar or
transcaval approaches are usually used (21-28). However,
if the endoleak sac is located at the anterior aspect of the
stent-graft, translumbar or transcaval approaches are less
feasible, and a transabdominal approach may be
warranted. 
All four patients with a type I endoleak had secondary
endovascular interventions to repair the type I endoleaks.
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Fig. 2. Steps for endoleak repair via transabdominal approach with
type l endoleak, 59-year-old patient with type l endoleak (No. 2).
A. Preprocedural CT showed type l endoleak (black arrows) within
aneurysm sac. Inferior mesenteric artery (white arrow) was exit
route for endoleak. Area previously treated with N-butyl cyanoacry-
late via transarterial approach for repair of type l endoleak can be
seen (asterisk).
B. Digital subtraction angiography via transabdominal approachC
showed type l endoleak (black arrow) with inferior mesenteric artery (white arrows). Embolization of endoleak sac using N-butyl
cyanoacrylate was performed (not shown). 
C. One-month follow-up CT showed complete repair of type l endoleak with radiopaque N-butyl cyanoacrylate in place of previous
endoleak sac. However, 1-year follow-up CT (not shown) showed increased diameter of aneurysm sac with indistinct type l endoleak and
patient eventually underwent surgical conversion.
Two patients (No. 3, 4) had a sufficient margin for stent-
graft extension. In patient No. 3, both an aortic extender
cuff and a Palmaz stent were placed. In patient No. 4, an
aortic extender cuff was placed. Two patients (No. 1, 2)
had no margin for placement of an aortic extender cuff for
the proximal type I endoleak, and no Palmaz stent was
available; therefore, balloon percutaneous angioplasty was
performed at the attachment site. These secondary
endovascular interventions had failed to repair the type I
endoleaks in all four patients with type I endoleaks.
Transarterial embolization was attempted in two patients
(No. 1, 2) as the next step. Patient No. 2 underwent
transarterial embolization using N-butyl cyanoacrylate.
However, the type I endoleak recurred on the 3-month
follow-up CT. The transarterial embolization of the
endoleak sac failed in patient No. 1. 
In two patients with a type II endoleak, transarterial
embolization failed in patient No. 5 because of tortuous
tracks from the internal iliac artery. In patient No. 6, a new
type II endoleak developed despite previously successful
transarterial embolization for the type II endoleak, on the
6-month follow-up CT. Open surgical repair or percuta-
neous transabdominal embolization was recommended for
all six patients. Because their general condition was
unfavorable for major surgery and they refused surgical
repair, embolization of the aneurysm sac was performed.
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Fig. 3. Steps for endoleak repair via transabdominal approach with type ll endoleak, 64-year-old patient with type ll endoleak (No. 6).
A. Preprocedural CT showed location of type ll endoleak (arrow) within aneurysm sac.
B. Digital subtraction angiography delineated size and structure of type ll endoleak, accessed via retrograde catheterization of inferior
mesenteric artery.
C. Embolization of endoleak sac using N-butyl cyanoacrylate was done by transarterial approach via inferior mesenteric artery.
D. Recurrence of new type ll endoleak (white arrow) that communicated with lumbar artery (black arrow) developed after six months of
follow-up.
C D
The advantage of direct endoleak embolization by the
translumbar or transcaval approach is that these methods
avoid traversing cavities or organs (21-29). Therefore,
these approaches are ideal when an endoleak is located at
the posterior aspect of the endovascular stent-graft or
when bowel or another organ is interposed (27). However,
when the endoleak sac is located at the anterior aspect of
the endovascular stent-graft, an anterior transabdominal
approach is needed for embolization of the endoleak sac.
The transabdominal approach has the advantage of being
performed with the patient in the supine position, so that
transarterial angiography can be performed simultane-
ously. Moreover, immediate confirmation of the angiogra-
phy results and accurate targeting can be achieved. The
risk of organ injury during the transabdominal approach
can be minimized when performed under fluoroscopic
and/or real-time US guidance. 
There were two cases with clinical failure (No. 2, 4).
Patient No. 2, who originally had a type I endoleak,
underwent an aortic extender cuff placement for repair of
a type I endoleak; however, a persistent type I endoleak
was observed during follow-up on CT. For treatment of
this endoleak, transarterial embolization was performed
with insufficient exclusion of the endoleak. The transab-
dominal approach was performed for the next procedure
and there was no visible endoleak on final aortography.
However, increased diameter of the aneurysm sac was
observed on the 1-year follow-up CT, raising the possibil-
ity of a recurrent type I endoleak. This case met our defini-
tion of a clinical failure, and surgical repair was
recommended; at surgery, there was no definite evidence
of an endoleak. We assumed that the cause of the
increased diameter of the aneurysm sac was a type V
endoleak or a subtle type I endoleak. Patient No. 4, who
also originally had a type I endoleak, underwent aortic
extender cuff placement for the repair of the type I
endoleak; however, a persistent type I endoleak was noted
during follow-up CT. When percutaneous transabdominal
embolization was performed, the type I endoleak was not
completely repaired and a patulous type I endoleak
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Fig. 3. Steps for endoleak repair via transabdominal approach with
type ll endoleak, 64-year-old patient with type ll endoleak (No. 6).
E. Digital subtraction angiography showed endoleak sac communi-
cating with lumbar artery (arrows). Transabdominal approach was
performed since main endoleak sac was located anteriorly.
F. Embolization of endoleak sac was performed using N-butyl
cyanoacrylate.
G. 3-year follow-up CT demonstrated complete repair of type ll
endoleak with radiopaque N-butyl cyanoacrylate in place of
previous endoleak sac.
E F
resulted. A percutaneous approach was inappropriate in
this case with a patulous type I endoleak. Surgical repair
was recommended. 
The results of this study suggest that when treatment of
an endoleak is considered necessary, and when the
endoleak sac is located at the anterior aspect of the stent-
graft, a percutaneous transabdominal approach to
embolization under both color-flow US and fluoroscopic
guidance is warranted. The percutaneous transabdominal
procedure for the treatment of type I or II endoleaks after
endovascular aneurysm repair is technically feasible and
should be considered an alternative method when conven-
tional endovascular methods have failed.
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